影响‘小凤兰’根状茎增殖、分化和壮苗的因素研究

以‘小凤兰’根状茎为试材,研究了影响‘小凤兰’根状茎增殖、分化、生根壮苗的因素。结果表明:MS基本培养基、蔗糖30g/L、6-BA 2.0mg/L+NAA 0.5mg/L、活性炭0.5g/L有利于根状茎增殖,而添加20%椰汁和番茄汁40g/L会抑制根状茎增殖。1/2MS基本培养基、蔗糖30g/L、6-BA 2.0mg/L+NAA 0.2mg/L、20%椰汁、1 000lx光照强度有利于根状茎分化,不加活性炭有利于芽分化,但抑制根分化,而添加活性炭则抑制芽分化,促进苗分化。添加土豆泥60g/L显著促进试管苗生长,3~4cm高的苗在培养基1/2MS+6-BA 0.1mg/L+NAA0.5mg/L+蔗糖20g/L+土豆泥60g/L+卡拉粉8g/L+活性炭0.5g/L中培养40d即可移栽。     

苹果园几种鸟雀驱避技术效果研究

选择种有"美国八号"(早熟)、"嘎啦"(中熟)、"富士"(晚熟)的混栽果园4片(各2/3hm~2)为研究对象,设置4个处理(分别为有色防鸟网、风动叶轮、超声波、生物驱避剂),对比了4种鸟雀驱避技术,调查其驱避效果,以筛选出最优的鸟雀驱避技术。结果表明:在相同品种条件下,4种鸟雀驱避技术防鸟害的有效程度以有色防鸟网驱避效果最好,持效性最长,稳定性最好;其受啄率分别为"美国八号"0.44%、"嘎啦"0.16%、"富士"0.20%。其次为生物驱避剂,其受啄率分别为"美国八号"1.92%、"嘎啦"2.24%、"富士"1.52%。然后为超声波驱避技术,其受啄率分别为"美国八号"9.64%、"嘎啦"5.56%,"富士"3.24%。驱避效果最差、持效性最短、稳定性最差的是风动叶轮驱鸟,其受啄率分别为"美国八号"10.00%、"嘎啦"6.52%、"富士"2.60%。3个品种综合调查结果表明,早熟苹果受啄率最高,其次是中熟品种,受啄率最低的是晚熟品种。     

新疆黄瓜品种对枯萎病的抗性鉴定评价

以黄瓜为试材,采用室内苗期孢子悬浮液灌根接种和田间土壤接菌鉴定的方法,研究了当地市场销售的23个黄瓜品种对枯萎病的抗性。结果表明:室内鉴定试验中,高抗品种3个,占13.0%;抗病品种5个,占21.7%;中抗品种9个,占39.1%;感病品种6个,占26.1%。田间鉴定试验中,高抗品种2个,占8.7%;抗病品种8个,占34.8%;中抗品种10个,占43.5%;感病品种3个,占13.0%。试验表明,供试的23个黄瓜品种中有10个品种属于高抗或抗病,适宜在当地推广种植。     

铁皮石斛优质试管苗繁育技术研究

以野生铁皮石斛为试材,采用限根培养法,研究了铁皮石斛种子非共生萌发特性及优质试管苗繁育技术。结果表明:授粉120d的种子达到生理成熟,能够顺利萌发;授粉140d种子达到形态成熟,萌发率可达98.51%;低温黑暗限制保存原球茎可控制其生长;在特定容器中用限根培养基MS+0.10mg·L~(-1) 6-BA+0.3mg·L~(-1) NAA+香蕉泥80g·L~(-1)培养小苗可得到优质试管苗;把试管苗移栽到松树皮中,成活率可达97.62%,该研究为铁皮石斛产业化育苗提供了新方法。     

对粮食主产区经济社会协调发展的思考

近十几年来,为国家粮食主产区的我国中部,却成为全国经济增长的"滞后地区",城镇居民人均可支配收入、农民人均收入均低于全国平均水平,形成了"中部塌陷".本文就中部崛起中,粮食主产区经济社会协调发展确保粮食安全问题进行了探讨.     

对北京市新型农村合作医疗制度的调查与思考

自2002年7月北京市大兴区率先在全国开展新型合作医疗试点至今,北京市新型农村合作医疗制度运行已经5年了.在对北京市新型农村合作医疗制度运行情况进行充分调研的基础上,总结了所取得的成效,分析了存在的问题,要进一步完善这项制度应提高筹资水平,实行动态缴费;提高补偿水平,提升制度吸引力;充实管办资源,重视调研能力建设等.     

Mutant-prevention concentrations of enrofloxacin for Escherichia coli isolates from chickens

OBJECTIVE: To investigate the development of enrofloxacin resistance among Escherichia coli isolates obtained from chickens by determining mutant-prevention concentrations (MPCs) and sequence the quinolone resistance-determining regions (QRDRs) of gyrA and parC genes in selected isolates. SAMPLE POPULATION: 15 chicken-derived E coli isolates. PROCEDURES: For all isolates, MPC and minimal inhibition concentration (MIC) of enrofloxacin were determined. The MPCs and maximum serum drug concentrations attained with enrofloxacin doses recommended for treatment of E coli infections in chickens were compared. Mutation frequencies and QRDR sequence changes in gyrA and parC were also determined. RESULTS: In 2 of 15 E coli strains, MPCs were low (0.016 and 0.062 microg/mL), MPC:MIC ratios were 2 and 4, and the GyrA and ParC proteins had no mutations. In 9 susceptible isolates with a GyrA point mutation, MPCs ranged from 2 to 16 microg/mL. For isolates with double mutations in GyrA and a single mutation in ParC, MPCs were > 32 microg/mL (several fold greater than the maximal plasma concentration of enrofloxacin in chickens); mutation frequencies were also much lower, compared with frequencies for single-mutation isolates. CONCLUSIONS AND CLINICAL RELEVANCE: For E coli infections of chickens, MPC appears to be useful for determining enrofloxacin-dosing strategies. The high MPC:MIC ratio may result in enrofloxacin-treatment failure in chickens infected with some wild-type gyrA E coli isolates despite the isolates' enrofloxacin susceptibility (MICs 0.125 to 1 microg/mL). For infections involving isolates with high MPCs, especially those containing mutations in gyrA and parC genes, treatment with combinations of antimicrobials should be adopted.     

Effect of diet with thiram on liver antioxidant capacity and tibial dyschondroplasia in broilers

1. An experiment was conducted to study the effect of thiram on liver antioxidant capacity and incidence of tibial dyschondroplasia in broilers. 2. One hundred and twenty Avian commercial broilers were allotted at random to three treatments: control group, low thiram group (50 mg/kg) and high thiram group (100 mg/kg). 3. Blood samples were collected to determine the activity of AST (aspartate aminotransferase). At the end of the trial, broilers were killed and liver samples were collected to determine the activity of SOD (superoxide dismutase), GSH-Px (glutathione peroxidase) and MDA (malondialdehyde) content, while the right proximal tibiotarsi were dissected in longitudinal section for assessment of tibial dyschondroplasia (TD) incidence and TD score. 4. The results showed that thiram increased the incidence of TD and TD scores, increased serum AST activity and MDA content of liver, and decreased the activity of SOD and GSH-Px in the liver. 5. They suggest that thiram causes TD in broilers by reducing liver antioxidation capability and damaging liver function; this may be one of the mechanisms by which thiram causes TD in broilers.     

Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2

Post-weaning multisystemic wating syndrome (PMWS) associated with PCV2 was one of the most costly diseases currently faced by the swine industry. In order to develop a vaccine to control this disease, we previously constructed a recombinant adenovirus expressing the capsid of PCV2. Here, we examined the protection of swine against PMWS by the recombinant adenovirus. Eighteen 32-day-old pigs were assigned to three groups each with six. Group 1 was vaccinated subcutaneously with rAd-Cap and boosted 2 weeks later. Thirty-seven days after first vaccination, Groups 1 and 2 were oronasally challenged with virulent PCV2 isolate, 4 and 7 days later, intramuscularly exposed to keyhole limpet hemocyanin (KLH). Group 3 remained unchallenged but with KLH. The results showed that high level of PCV2-specific ELISA antibody and neutralizing antibody could be induced at 37 days after first vaccination. After challenge, pigs in vaccinated group had no clearly clinical signs, although some of them had increased rectal temperatures (>/=40 degrees C) for short time. The pyrexic phase in vaccinated group was significantly lighter than that in challenge-control group (P<0.05). The relative daily weight gain in vaccinated-challenged group was similar to that in empty control group. But it was significantly high compared to the challenge-control group (P<0.05). Mean while the pathological lesions and virema presented in vaccinated group were milder than those in control group. It indicated that the recombinant adenovirus was able to confer significant protection against clinical disease and reduce pathogenic lesions induced by PCV2 challenge, even though it could not provide complete virological protection. The recombinant adenovirus might be an attractive candidate vaccine for preventing the disease associated with PCV2 infection.